Collection of samples from homes for COVID-19 testing, now available

Datuk Dr Noor Hisham Abdullah - Bernama file picture

PUTRAJAYA, March 9 -- The Ministry of Health (MoH), in collaboration with the private hospitals and healthcare providers, today launched the service for collection of samples for COVID-19 testing from the homes of individuals who wish to test for the disease but do not meet the patient under investigation (PUI) criteria.

Health director-general Datuk Dr Noor Hisham Abdullah said with the collaboration, asymptomatic individuals can undergo COVID-19 testing at their own homes without having to go to a health facility.

“Currently, sampling is only carried out on those identified as PUI cases, but there are those who are concerned and want to get the COVID-19 test done but do not meet the PUI criteria.

“Hence, those who want to undergo this test can obtain it from the private healthcare facilities,” he told a press conference on 'Uberisation and Collection of Samples for COVID-19 at Home' here today.

Currently, there are 11 private companies involved in providing COVID-19 sampling services at home and the list will be updated from time to time.

The companies involved are Bookdoc, DoctorOnCall, Pantai Premier Pathology Sdn Bhd, Lablink (M) Sdn Bhd (KPJ), Qualitas Medical Group Sdn Bhd, Gleneagles Kuala Lumpur, Twin Tower Medical Centre KLCC, Pantai Hospital (Kuala Lumpur), Pantai Hospital (Cheras), Pantai Hospital (Klang) and Pantai Hospital Ayer Keroh, in Melaka.

Dr Noor Hisham said the sampling services would be performed by trained medical personnel and the samples would then be sent to a private laboratory for analysis.

“The home sampling of COVID-19 is subject to charges imposed by the private healthcare facility,” he said.

He said the collaboration with private medical providers would ease the presence of the public at the government hospitals and health clinics to undergo COVID-19 test.

The public can access the service by downloading the related application, to schedule the home visit appointment for sample collection purposes or visit the company's website for more information, he said.






Vivantis Technologies Elevates COVID-19 Testing Capacity In Malaysia

By Nadia Jumri

KUALA LUMPUR (Bernama) – The world has been battling COVID-19 for close to a year now, with more than 200 countries and territories affected by the pandemic.

In Malaysia, the third wave of infections led to total case numbers spiking to over 75,000. Globally, the virus has infected more than 68 million people and caused over 1.5 million fatalities.

Due to the virus’ highly virulent nature, producing COVID-19 test kits has become a top priority for certain biotechnology companies focusing on research and development (R&D) in Malaysia.



Pandangan rakyat Malaysia tentang peningkatan sasaran pemberian vaksin COVID-19 kepada 70 peratus.

UMSC: Pain Management

In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1